dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pascual García, Mónica |
dc.contributor.author | Bonfill Teixidor, Ester |
dc.contributor.author | Planas Rigol, Ester |
dc.contributor.author | Rubio-Perez, Carlota |
dc.contributor.author | Iurlaro, Raffaella |
dc.contributor.author | Arias Piñeiro, Alexandra |
dc.contributor.author | Cuartas Maza, Ma Isabel |
dc.contributor.author | Sala Hojman, Ada |
dc.contributor.author | Escudero Monreal, Laura |
dc.contributor.author | Martínez Ricarte, Francisco Ramón |
dc.contributor.author | Huber Ruano, Isabel |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Braña Garcia, Irene |
dc.contributor.author | Garralda Cabanas, Elena |
dc.contributor.author | Vieito Villar, Maria |
dc.contributor.author | Espejo Ruiz, Carmen |
dc.contributor.author | Sahuquillo Barris, Joan |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Seoane Suarez, Joan |
dc.date.accessioned | 2019-07-31T10:01:10Z |
dc.date.available | 2019-07-31T10:01:10Z |
dc.date.issued | 2019-06-11 |
dc.identifier.citation | Pascual-García M, Bonfill-Teixidor E, Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10(1):2416. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/4218 |
dc.description | Càncer; Macròfags associats al tumor: LIF; CD8 |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Nature Communications;10(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antineoplàstics |
dc.subject | Cèl·lules T - Immunologia |
dc.subject | Citocines - Immunologia |
dc.subject | Tumors - Tractament |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Leukemia Inhibitory Factor |
dc.subject.mesh | CD8-Positive T-Lymphocytes |
dc.subject.mesh | /immunology |
dc.title | LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-019-10369-9 |
dc.subject.decs | neoplasias |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | factor inhibidor de la leucemia |
dc.subject.decs | linfocitos T CD8-positivos |
dc.subject.decs | /inmunología |
dc.relation.publishversion | https://www.nature.com/articles/s41467-019-10369-9 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pascual-García M, Bonfill-Teixidor E] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. [Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, Cuartas I, Sala-Hojman A, Escudero L, Huber-Ruano I, Nuciforo P, Braña I, Garralda E, Vieito M] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Martínez-Ricarte F, Espejo C, Sahuquillo J] Vall d’Hebron Institut de Recerca, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. [Tabernero J] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. [Seoane J] Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERONC, Madrid, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. |
dc.identifier.pmid | 31186412 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |